Exact Sciences
EXAS
NASDAQ
IPO2001
about EXAS
Exact Sciences develops innovative at-home diagnostic tests for early cancer detection, including those for colorectal, breast, and other cancers.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $64.85 | $65.00 | $63.30 | $12.24B | 2.99M |
| eps |
price to earnings |
price to sales |
operating margin |
profit margin |
yield |
| -$0.01 | n/a | 14.91 | -0.26% | -0.15% | 0% |